142 related articles for article (PubMed ID: 16629406)
1. Inhibition of beta-1,3-glucan synthase and cell growth of Cryptococcus species by recombinant single-chain anti-idiotypic antibodies.
Selvakumar D; Miyamoto M; Furuichi Y; Komiyama T
J Antibiot (Tokyo); 2006 Feb; 59(2):73-9. PubMed ID: 16629406
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of fungal beta-1,3-glucan synthase and cell growth by HM-1 killer toxin single-chain anti-idiotypic antibodies.
Selvakumar D; Miyamoto M; Furuichi Y; Komiyama T
Antimicrob Agents Chemother; 2006 Sep; 50(9):3090-7. PubMed ID: 16940106
[TBL] [Abstract][Full Text] [Related]
3. Peptide derived from anti-idiotypic single-chain antibody is a potent antifungal agent compared to its parent fungicide HM-1 killer toxin peptide.
Kabir ME; Karim N; Krishnaswamy S; Selvakumar D; Miyamoto M; Furuichi Y; Komiyama T
Appl Microbiol Biotechnol; 2011 Dec; 92(6):1151-60. PubMed ID: 21691785
[TBL] [Abstract][Full Text] [Related]
4. Recombinant single-chain anti-idiotypic antibody: an effective fungal beta-1,3-glucan synthase inhibitor.
Selvakumar D; Karim N; Miyamoto M; Furuichi Y; Komiyama T
Biol Pharm Bull; 2006 Sep; 29(9):1848-53. PubMed ID: 16946497
[TBL] [Abstract][Full Text] [Related]
5. An altered camelid-like single domain anti-idiotypic antibody fragment of HM-1 killer toxin: acts as an effective antifungal agent.
Kabir ME; Krishnaswamy S; Miyamoto M; Furuichi Y; Komiyama T
Appl Microbiol Biotechnol; 2011 Apr; 90(2):553-64. PubMed ID: 21305279
[TBL] [Abstract][Full Text] [Related]
6. Different buffer effects in selecting HM-1 killer toxin single-chain fragment variable anti-idiotypic antibodies.
Krishnaswamy S; Kabir ME; Miyamoto M; Furuichi Y; Komiyama T
J Biochem; 2010 May; 147(5):723-33. PubMed ID: 20097900
[TBL] [Abstract][Full Text] [Related]
7. Isolation and characterization of recombinant single chain fragment variable anti-idiotypic antibody specific to Aspergillus fumigatus membrane protein.
Krishnaswamy S; Kabir ME; Rahman MM; Miyamoto M; Furuichi Y; Komiyama T
J Immunol Methods; 2011 Mar; 366(1-2):60-8. PubMed ID: 21277307
[TBL] [Abstract][Full Text] [Related]
8. New avenues for phage-display library to produce a Cryptococcus-specific anti-idiotypic antibody of HM-1 killer toxin.
Rahman MM; Kabir ME; Krishnaswamy S; Miyamoto M; Furuichi Y; Komiyama T
J Mol Recognit; 2011; 24(4):631-41. PubMed ID: 21584874
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of a monoclonal killer anti-idiotypic antibody and a synthetic killer peptide against oral isolates of Candida spp. differently susceptible to conventional antifungals.
Manfredi M; McCullough MJ; Conti S; Polonelli L; Vescovi P; Al-Karaawi ZM; Porter SR
Oral Microbiol Immunol; 2005 Aug; 20(4):226-32. PubMed ID: 15943767
[TBL] [Abstract][Full Text] [Related]
10. A synthetic peptide as a novel anticryptococcal agent.
Cenci E; Bistoni F; Mencacci A; Perito S; Magliani W; Conti S; Polonelli L; Vecchiarelli A
Cell Microbiol; 2004 Oct; 6(10):953-61. PubMed ID: 15339270
[TBL] [Abstract][Full Text] [Related]
11. Cloning antifungal single chain fragment variable antibodies by phage display and competitive panning elution.
Krishnaswamy S; Kabir ME; Miyamoto M; Furuichi Y; Komiyama T
Anal Biochem; 2009 Dec; 395(1):16-24. PubMed ID: 19665444
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic potential of antiidiotypic single chain antibodies with yeast killer toxin activity.
Magliani W; Conti S; de Bernardis F; Gerloni M; Bertolotti D; Mozzoni P; Cassone A; Polonelli L
Nat Biotechnol; 1997 Feb; 15(2):155-8. PubMed ID: 9035141
[TBL] [Abstract][Full Text] [Related]
13. Cryptococcus neoformans resistance to echinocandins: (1,3)beta-glucan synthase activity is sensitive to echinocandins.
Maligie MA; Selitrennikoff CP
Antimicrob Agents Chemother; 2005 Jul; 49(7):2851-6. PubMed ID: 15980360
[TBL] [Abstract][Full Text] [Related]
14. Conditional lethality of the diprotic weak bases chloroquine and quinacrine against Cryptococcus neoformans.
Harrison TS; Griffin GE; Levitz SM
J Infect Dis; 2000 Jul; 182(1):283-9. PubMed ID: 10882608
[TBL] [Abstract][Full Text] [Related]
15. The human immunodeficiency virus (HIV) protease inhibitor indinavir directly affects the opportunistic fungal pathogen Cryptococcus neoformans.
Blasi E; Colombari B; Orsi CF; Pinti M; Troiano L; Cossarizza A; Esposito R; Peppoloni S; Mussini C; Neglia R
FEMS Immunol Med Microbiol; 2004 Oct; 42(2):187-95. PubMed ID: 15364103
[TBL] [Abstract][Full Text] [Related]
16. An improved phage-display panning method to produce an HM-1 killer toxin anti-idiotypic antibody.
Kabir ME; Krishnaswamy S; Miyamoto M; Furuichi Y; Komiyama T
BMC Biotechnol; 2009 Dec; 9():99. PubMed ID: 20003392
[TBL] [Abstract][Full Text] [Related]
17. In vitro susceptibilities of Malaysian clinical isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii to five antifungal drugs.
Tay ST; Tanty Haryanty T; Ng KP; Rohani MY; Hamimah H
Mycoses; 2006 Jul; 49(4):324-30. PubMed ID: 16784448
[TBL] [Abstract][Full Text] [Related]
18. Killer anti-idiotypes in the control of fungal infections.
Magliani W; Conti S; Arseni S; Frazzi R; Salati A; Polonelli L
Curr Opin Investig Drugs; 2001 Apr; 2(4):477-9. PubMed ID: 11566002
[TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of a neutralizing monoclonal antibody for the epitope on HM-1 killer toxin.
Selvakumar D; Zhang QZ; Miyamoto M; Furuichi Y; Komiyama T
J Biochem; 2006 Mar; 139(3):399-406. PubMed ID: 16567405
[TBL] [Abstract][Full Text] [Related]
20. A novel monoclonal antibody recognizing beta(1-3) glucans in intact cells of Candida and Cryptococcus.
Kondori N; Edebo L; Mattsby-Baltzer I
APMIS; 2008 Oct; 116(10):867-76. PubMed ID: 19132980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
